4.7 Article

CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells

Journal

BLOOD
Volume 128, Issue 3, Pages 371-383

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2015-08-661785

Keywords

-

Categories

Funding

  1. Leukaemia and Lymphoma Research [11017, 13035, 08071]
  2. Kay Kendall Leukaemia Fund [690, 501]
  3. Howat Foundation
  4. Friends of Paul O'Gorman
  5. Cancer Research UK [C11074/A11008]
  6. Biotechnology and Biological Sciences Research Council [BB/F016050/1]
  7. Medical Research Council [G0600782, MR/K014854/1]
  8. Cancer Research UK Glasgow Centre [C596/A18076]
  9. Biological Service Unit facilities at the Cancer Research UK Beatson Institute [C596/A17196]
  10. Glasgow Experimental Cancer Medicine Centre (Cancer Research UK)
  11. Glasgow Experimental Cancer Medicine Centre (Chief Scientist's Office, Scotland)
  12. MRC [G0901113, MR/M019764/1, G0600782, MR/K014854/1] Funding Source: UKRI
  13. Cancer Research UK [15673, 11008, 14633] Funding Source: researchfish
  14. Medical Research Council [G0901113, MR/K014854/1, MR/M019764/1, G0600782] Funding Source: researchfish
  15. Versus Arthritis
  16. Cancer Research UK [21139] Funding Source: researchfish
  17. Wellcome Trust [099251/Z/12/Z] Funding Source: researchfish

Ask authors/readers for more resources

The regulation of hematopoietic stem cell (HSC) survival and self-renewal within the bone marrow (BM) niche is not well understood. We therefore investigated global transcriptomic profiling of normal human HSC/hematopoietic progenitor cells [HPCs], revealing that several chemokine ligands (CXCL1-4, CXCL6, CXCL10, CXCL11, and CXCL13) were upregulated in human quiescent CD34(+)Hoescht(-)Pyronin Y- and primitive CD34(+)38(-), as compared with proliferating CD34(+)Hoechst(+)Pyronin Y+ and CD34(+)38(+) stem/progenitor cells. This suggested that chemokines might play an important role in the homeostasis of HSCs. In human CD34(+) hematopoietic cells, knockdown of CXCL4 or pharmacologic inhibition of the chemokine receptor CXCR2, significantly decreased cell viability and colony forming cell (CFC) potential. Studies on Cxcr2(-/-) mice demonstrated enhanced BM and spleen cellularity, with significantly increased numbers of HSCs, hematopoietic progenitor cell-1 (HPC-1), HPC-2, and Lin(-)Sca-1(+)c-Kit(+) subpopulations. Cxcr2(-/-) stem/progenitor cells showed reduced self-renewal capacity as measured in serial transplantation assays. Parallel studies on Cxcl4 demonstrated reduced numbers of CFC in primary and secondary assays following knockdown in murine c-Kit(+) cells, and Cxcl4(-/-) mice showed a decrease in HSC and reduced self-renewal capacity after secondary transplantation. These data demonstrate that the CXCR2 network and CXCL4 play a role in the maintenance of normal HSC/HPC cell fates, including survival and self-renewal.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY

Amelia Green, Helen Curtis, William Hulme, Elizabeth Williamson, Helen McDonald, Krishnan Bhaskaran, Christopher Rentsch, Anna Schultze, Brian MacKenna, Viyaasan Mahalingasivam, Laurie Tomlinson, Alex Walker, Louis Fisher, Jon Massey, Colm Andrews, Lisa Hopcroft, Caroline Morton, Richard Croker, Jessica Morley, Amir Mehrkar, Seb Bacon, David Evans, Peter Inglesby, George Hickman, Tom Ward, Simon Davy, Rohini Mathur, John Tazare, Rosalind Eggo, Kevin Wing, Angel Wong, Harriet Forbes, Chris Bates, Jonathan Cockburn, John Parry, Frank Hester, Sam Harper, Ian Douglas, Stephen Evans, Liam Smeeth, Ben Goldacre

Summary: While the majority of COVID-19 vaccine breakthrough cases in England were mild, some differences in rates of breakthrough cases have been identified in several clinical groups. Further analysis is needed to assess vaccine waning and rates of breakthrough COVID-19 between different variants in order to identify individuals at higher risk.

BMC MEDICINE (2022)

Article Oncology

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)

Grant D. Stewart, Sarah J. Welsh, Stephan Ursprung, Ferdia A. Gallagher, James O. Jones, Jacqui Shields, Christopher G. Smith, Thomas J. Mitchell, Anne Y. Warren, Axel Bex, Ekaterini Boleti, Jade Carruthers, Tim Eisen, Kate Fife, Abdel Hamid, Alexander Laird, Steve Leung, Jahangeer Malik, Iosif A. Mendichovszky, Faiz Mumtaz, Grenville Oades, Andrew N. Priest, Antony C. P. Riddick, Balaji Venugopal, Michelle Welsh, Kathleen Riddle, Lisa E. M. Hopcroft, Robert J. Jones

Summary: The study demonstrates that axitinib can reduce the level of VTT in patients, leading to a reduction in the extent of surgery for a significant proportion of patients. However, some patients show poor response to axitinib.

BRITISH JOURNAL OF CANCER (2022)

Letter Dermatology

Eukaryotic Elongation Factor 2 Kinase Activity Is Required for the Phenotypes of the Rpl24Bst Mouse

John R. P. Knight, Christopher G. Proud, Giovanna Mallucci, Tobias von der Haar, C. Mark Smales, Anne E. Willis, Owen J. Sansom

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Multidisciplinary Sciences

Retrograde movements determine effective stem cell numbers in the intestine

Maria Azkanaz, Bernat Corominas-Murtra, Saskia I. J. Ellenbroek, Lotte Bruens, Anna T. Webb, Dimitrios Laskaris, Koen C. Oost, Simona J. A. Lafirenze, Karl Annusver, Hendrik A. Messal, Sharif Iqbal, Dustin J. Flanagan, David J. Huels, Felipe Rojas-Rodriguez, Miguel Vizoso, Maria Kasper, Owen J. Sansom, Hugo J. Snippert, Prisca Liberali, Benjamin D. Simons, Pekka Katajisto, Edouard Hannezo, Jacco van Rheenen

Summary: The number and behavior of stem cells vary along the intestinal tract, with small intestines having twice as many effective stem cells as large intestines. This difference is attributed to the presence of retrograde cellular movement in small intestines, which allows cells positioned away from the crypt base to function as long-term effective stem cells.

NATURE (2022)

Article Biochemistry & Molecular Biology

Hepatic glutamine synthetase controls N5-methylglutamine in homeostasis and cancer

Victor H. Villar, Maria Francesca Allega, Ruhi Deshmukh, Tobias Ackermann, Mark A. Nakasone, Johan Vande Voorde, Thomas M. Drake, Janina Oetjen, Algernon Bloom, Colin Nixon, Miryam Muller, Stephanie May, Ee Hong Tan, Lars Vereecke, Maude Jans, Gillian Blancke, Daniel J. Murphy, Danny T. Huang, David Y. Lewis, Thomas G. Bird, Owen J. Sansom, Karen Blyth, David Sumpton, Saverio Tardito

Summary: This study reveals that glutamine synthetase (GS) can produce a methylated glutamine analog, N-5-methylglutamine, during the synthesis of glutamine. GS inhibition leads to decreased levels of N-5-methylglutamine in the liver and circulation in mice. The levels of N-5-methylglutamine in urine correlate with tumor burden and GS expression in a liver cancer model.

NATURE CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells

Fuhui Chen, Sevim B. Gurler, David Novo, Cigdem Selli, Denis G. Alferez, Secil Eroglu, Kyriaki Pavlou, Jingwei Zhang, Andrew H. Sims, Neil E. Humphreys, Antony Adamson, Andrew Campbell, Owen J. Sansom, Cathy Tournier, Robert B. Clarke, Keith Brennan, Charles H. Streuli, Ahmet Ucar

Summary: Breast cancer stem cells (BCSC), responsible for treatment resistance, tumor recurrence, and metastasis, have been hindered by heterogeneity and lack of selective molecular targets. This study identifies RAC1B as a clinically relevant molecular target for BCSC-targeting therapies, highlighting its role in the maintenance of BCSC and their chemoresistance to doxorubicin.

ONCOGENE (2023)

Article Oncology

Genetically engineered multicistronic allele of Pmel yielding highly specific CreERT2-mediated recombination in the melanocyte lineage

Emma L. Wilkinson, Louise C. Brennan, Olivia J. Harrison, Zoe Crane-Smith, Philippe Gautier, Margaret A. Keighren, Peter Budd, Karthic Swaminathan, Laura M. Machesky, Sarah L. Allinson, Ian J. Jackson, Richard L. Mort

Summary: Genetic approaches are crucial for studying melanocytes and melanoma. Current methods for labeling melanocytes in mice have limitations, but researchers have successfully generated a targeted multicistronic allele using homologous recombination in mouse embryonic stem cells, allowing specific labeling and live imaging of melanocytes. This transgenic allele has been demonstrated to be useful in embryonic and adult tissues.

PIGMENT CELL & MELANOMA RESEARCH (2023)

Article Multidisciplinary Sciences

A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection

Clara Calvert, Jade Carruthers, Cheryl Denny, Jack Donaghy, Lisa E. M. Hopcroft, Leanne Hopkins, Anna Goulding, Laura Lindsay, Terry McLaughlin, Emily Moore, Bob Taylor, Maria Loane, Helen Dolk, Joan Morris, Bonnie Auyeung, Krishnan Bhaskaran, Cheryl L. Gibbons, Srinivasa Vittal Katikireddi, Maureen O'Leary, David McAllister, Ting Shi, Colin R. Simpson, Chris Robertson, Aziz Sheikh, Sarah J. Stock, Rachael Wood

Summary: This study using electronic health records from Scotland found no increased risk of congenital anomalies associated with COVID-19 vaccination or SARS-CoV-2 infection during early pregnancy.

NATURE COMMUNICATIONS (2023)

Review Biochemistry & Molecular Biology

CYRI proteins: controllers of actin dynamics in the cellular ?eat vs walk? decision

Laura M. Machesky

Summary: Cells use actin-based protrusions to migrate, sample their environment, and take up liquids and particles. Lamellipodia and macropinocytic cups are involved in cell migration and uptake of surrounding substances. The regulation between these functions is not well understood.

BIOCHEMICAL SOCIETY TRANSACTIONS (2023)

Editorial Material Cell Biology

Deadly actin collapse by disulfidptosis

Laura M. Machesky

Summary: Programmed cell death (PCD) helps cells to benefit the surviving organism. A recent study shows that cells can program their death by inducing extensive disulfide bonding of the actin cytoskeleton in response to an imbalance of cystine, a raw material for glutathione production.

NATURE CELL BIOLOGY (2023)

Article Medical Informatics

Data-Driven Identification of Unusual Prescribing Behavior: Analysis and Use of an Interactive Data Tool Using 6 Months of Primary Care Data From 6500 Practices in England

Lisa E. M. Hopcroft, Jon Massey, Helen J. Curtis, Brian Mackenna, Richard Croker, Andrew Brown, Thomas O'Dwyer, Orla Macdonald, David Evans, Peter Inglesby, Sebastian C. J. Bacon, Ben Goldacre, Alex J. Walker

Summary: This study developed and applied a hypothesis-free algorithm to identify unusual prescribing behavior in primary care data in England. The results were visualized using interactive dashboards, demonstrating the potential of data-driven approaches in identifying targets for improved healthcare delivery.

JMIR MEDICAL INFORMATICS (2023)

Article Oncology

mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia

Natasha Malik, Jodie Hay, Hassan N. B. Almuhanna, Karen M. Dunn, Jamie Lees, Jennifer Cassels, Jiatian Li, Rinako Nakagawa, Owen J. Sansom, Alison M. Michie

Summary: This study reveals the essential role of mTORC1 in the initiation/maintenance of leukemia in a CLL model and identifies the inactivation of eEF2 activity as a novel therapeutic target for blocking CLL progression.

LEUKEMIA (2023)

Editorial Material Biology

A new Editor-in-Chief and new future for Biology Open

Laura Machesky

BIOLOGY OPEN (2023)

Article Hematology

Platelet zinc status regulates prostaglandin-induced signaling, altering thrombus formation

Charlie A. Coupland, Leigh Naylor-Adamson, Zoe Booth, Thomas W. Price, Helio M. Gil, George Firth, Michelle Avery, Yusra Ahmed, Graeme J. Stasiuk, Simon D. J. Calaminus

Summary: Approximately 17.3% of the global population suffers from zinc (Zn2+) deficiency, which leads to increased bleeding due to impaired hemostasis. Zinc ion (Zn2+) has the ability to modulate platelet signaling through the endothelial-derived prostacyclin I2 (PGI2) pathway, affecting thrombus formation and hemostasis.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Review Oncology

Therapeutic targeting of tumour myeloid cells

Simon T. Barry, Dmitry I. Gabrilovich, Owen J. Sansom, Andrew D. Campbell, Jennifer P. Morton

Summary: Myeloid cells in the tumour microenvironment have a significant impact on tumour progression, making them a key target for clinical therapies. However, large-scale clinical trials targeting these cells have had limited success. Understanding the specific functions and roles of different myeloid cell subpopulations within the tumour microenvironment could improve the design of successful clinical trials for myeloid-targeting therapies.

NATURE REVIEWS CANCER (2023)

No Data Available